|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0108 - 0.0140|
|52 Week Range||0.0010 - 0.0180|
|Beta (3Y Monthly)||1.33|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 7, 2019 - Feb 11, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Verus International, Inc. (“Verus” or the “Company”) today announced financial results for its fiscal 2019 first quarter ended January 31, 2019. In conjunction with this release, the Company is also providing a more detailed description of its strategy for fiscal 2019. The company’s gross margin was approximately 15%, in the higher expected range for the current product mix.
Verus International, Inc. (“Verus” or the “Company”) today announced financial results for its fiscal 2018 fourth quarter and full year ended October 31, 2018. In conjunction with this release, the Company will also provide additional details on its strategy for fiscal 2019. In fiscal 2018, Verus posted sales of $5.8 million, a 101% increase over the $2.9 million registered in fiscal 2017.
Verus International, Inc. (“Verus” or the “Company”) is pleased to announce that it has received an order from a distributor to deliver approximately $4 million worth of rice annually for the Dubai market. Verus will source three to four varieties of rice from multiple producers in India to meet this initial demand. Under the terms of the agreement, Verus will sell rice under both the supplier’s brand name and a Verus brand.
Verus International, Inc. (“Verus” or the “Company”) is pleased to announce that it has signed an agreement to supply honey products in Europe and parts of the Middle East. The contract will focus particularly on the United Kingdom and Germany, but will include a dozen countries in Europe and the Middle East. Depending upon the market, Verus will offer from 20 to 30 different stock keeping units (SKUs) covering a broad range of honey categories and product sizes.
Gaithersburg, MD, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Verus International, Inc. (“Verus” or the “Company”) is pleased to announce that it has received $1.45 million in funding, as detailed in a Form 8-K filed today. Concurrent with this funding, Verus is pleased to announce that it has retired all of the variable rate convertible notes (“toxic notes”) held by four separate creditors. This action is particularly important because it will enable Verus to remove a sizeable reserve from its balance sheet and avoid paying millions of dollars in penalties and other charges.